Spots Global Cancer Trial Database for chemonaive
Every month we try and update this database with for chemonaive cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Bendamustine With Irinotecan Followed by Etoposide/Carboplatin for Patients With Extensive Stage Small Cell Lung Cancer | NCT00856830 | Small Cell Lung... Extensive Stage... Chemonaive | Novel Drug Comb... | 18 Years - 79 Years | University of Alabama at Birmingham | |
IPI Biochemotherapy for Chemonaive Patients With Metastatic Melanoma | NCT01409174 | Melanoma | Ipilimumab Temozolomide Cisplatin Interferon Alfa... Interleukin-2 | 18 Years - 65 Years | M.D. Anderson Cancer Center | |
Study of Erlotinib (Tarceva®) in Combination With OSI-906 in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) With Activating Mutations of the Epidermal Growth Factor Receptor (EGFR) Gene | NCT01221077 | NSCLC Non Small Cell ... | OSI-906 Erlotinib Placebo | 18 Years - | Astellas Pharma Inc |